Ulrich Medical DIGITAL

Research date: 28 October 2026

Target: ulrich medical

Legal entity: ulrich GmbH & Co. KG

Scope: Enterprise technology, digital medical products, software integrations, cloud infrastructure, data processing, Israeli technology-sector relationships, controlling principals, subsidiaries, and digital services potentially involving Israeli institutions or occupied territories.

Enterprise Technology Stack & Vendor Relationships

Corporate identity and ownership

Ulrich Medical operates under the legal entity ulrich GmbH & Co. KG, registered in Ulm, Germany. Its published legal notice identifies ulrich Verwaltungs GmbH as the personally liable partner, Christoph Ulrich as managing partner, Friedrich von Rechteren as CEO and Gordon Bittig as CFO. These particulars were published on the company’s website and remained publicly displayed on 28 October 2026. The duration of each underlying ownership interest is not established by the notice.¹

The company traces its foundation to Heinrich C. Ulrich in 1912. Its corporate history describes the transfer of management from Heiner Ulrich to his son Christoph Ulrich in 2009 and identifies the business as an independent family company. The historical ownership percentages are not disclosed on this page.²

Ulrich Medical’s management page identifies Friedrich von Rechteren as CEO and Chairman from 1 June 2025, Christoph Ulrich as managing partner, and Gordon Bittig as CFO. It identifies Sven Erdmann, Steffen Kölsch and Cornelia Schweizer as additional senior management members. These appointments were reflected in the current public management profile examined in October 2026.³

Ulrich Medical’s 14 January 2026 announcement confirms the management structure comprising Friedrich von Rechteren, Christoph Ulrich and Gordon Bittig. No percentage ownership information is provided in that announcement.⁴

Integrated corporate entities

The German parent identifies subsidiaries in the United States, France and Spain. Its current locations page places these operations in the Dallas, Toulouse and Madrid regions and describes distribution through specialist distributors in additional countries. The identity of every distributor is not published on this page.⁵

Ulrich medical USA, Inc. was founded in January 2006 and has been based in the Dallas area since 2023. The subsidiary describes direct distribution of spinal systems and product development tailored to the US market. Its operational and development activities were still described publicly in October 2026.⁶

Ulrich medical France SAS was founded in October 2017 and is described as a wholly owned French subsidiary. Its product activities cover radiology and spinal surgery, with the spinal portfolio expanded in 2021. The relationship was publicly represented as continuing in October 2026.⁷

Ulrich medical España S.L. began operations in 2024, with direct distribution of contrast-media injectors from Madrid. The corporate profile identifies Christophe Martinez as General Manager. The subsidiary was publicly represented as operating in October 2026.⁸

ULRICH Swiss publicly identifies itself as an independent company founded by a relative of Ulrich Medical’s founder. It reports becoming Ulrich Medical’s exclusive Swiss distributor in April 2022. The relationship is represented as continuing on the distributor’s current website; ULRICH Swiss is not thereby established as a subsidiary of the German company.⁹

Verified enterprise software

Ulrich GmbH & Co. KG’s published privacy statement identifies Microsoft Dynamics 365 Customer Insights – Journeys as the software used for its newsletter and associated marketing processing. The stated provider is Microsoft Corporation. The precise contract commencement date is not published; the disclosure was available in October 2026.¹⁰

The same privacy statement identifies Microsoft Teams for online meetings, conferences, webinars and document exchange. It describes Microsoft as the provider and discusses possible processing on US servers. The relationship is publicly disclosed as active, but specific hosting regions and contract dates are not established.¹⁰

Ulrich Medical identifies Google Analytics 4 as its website analytics service and Google Ads conversion tracking as an advertising measurement service. The privacy statement describes processing of website interactions and analytics information, subject to its stated consent arrangements. The exact adoption dates are not identified.¹⁰

Israeli-origin enterprise vendors

No public evidence identified of direct licensing, procurement or integration involving Check Point, Wiz, SentinelOne, CyberArk, NICE, Verint, Claroty, Palo Alto Networks, or another specifically identified Israeli-origin cybersecurity or enterprise software supplier.

No public evidence identified establishing that an Ulrich Medical enterprise systems integrator deployed Israeli-origin technology.

Commercial technology partnerships

Ulrich Medical’s July 2024 corporate announcement identifies GE Healthcare and Bracco Imaging as international commercial partners. It does not establish that either supplied an Israeli-origin cybersecurity, surveillance or government-cloud system to Ulrich Medical.¹¹

Ulrich Medical’s radiology information describes a commercial agreement under which GE Healthcare distributes the CT motion injector in the United States under the GE Healthcare brand. This is a medical-device distribution relationship; the publication does not establish an Israeli government or military technology deployment.¹²

Synapse Medical, part of Uniphar Medtech, identifies itself as Ulrich Medical’s third-largest global distributor by 2025 sales volume and describes expanding distribution across Ireland, Great Britain, Belgium and the Netherlands. The distributor publicly presented this as a continuing relationship, but individual software-module sales are not identified.¹³

Named-entity investigation record

• ulrich GmbH & Co. KG: German parent and operating company. Searched for Israeli software procurement, military contracts, cyber infrastructure and digital services. Its disclosed digital products and enterprise vendors are described in this audit; no Israeli-origin enterprise technology contract was verified.^{1, 10}
• ulrich Verwaltungs GmbH: Personally liable partner. Searched for Israeli technology ownership, acquisitions and investments; searched, none found.¹
• Christoph Ulrich: Managing partner and family controlling principal. Searched for Israeli cyber, military technology and investment relationships; searched, none found.³
• Friedrich von Rechteren: CEO and Chairman. Searched for Israeli technology, defence-sector and investment links; searched, none found.⁴
• Gordon Bittig: CFO. Searched for Israeli cyber and defence-technology relationships; searched, none found.⁴
• Klaus Kiesel: Former CEO. Searched for Israeli technology and defence-industry relationships; searched, none found.¹¹
• Heiner Ulrich: Historical family executive. Searched for Israeli technology and defence-industry relationships; searched, none found.²
• Heinrich C. Ulrich: Founder. Searched by name in connection with ownership history and Israeli technology relationships; searched, none found.²
• Sven Erdmann: Senior executive responsible for technology and regulation. Searched for Israeli cybersecurity, military and technology relationships; searched, none found.³
• Steffen Kölsch: Senior executive responsible for operations and quality. Searched for Israeli technology and defence relationships; searched, none found.³
• Cornelia Schweizer: Senior sales and marketing executive. Searched for Israeli digital technology and defence relationships; searched, none found.³
• ulrich medical USA, Inc.: US subsidiary. Searched for Israeli military technology, procurement and software partnerships; searched, none found.⁶
• Eric Gibbs: US General Manager. Searched for Israeli defence and technology relationships; searched, none found.⁶
• Eric Lucas: Global R&D executive. Searched for Israeli technology investment and research relationships; searched, none found.⁶
• Johnny Drake: US commercial executive. Searched for Israeli government and military procurement relationships; searched, none found.⁶
• Lou Milos: US quality executive. Searched for Israeli defence and technology relationships; searched, none found.⁶
• Michael Gow: US business development executive. Searched for Israeli military technology and investment relationships; searched, none found.⁶
• ulrich medical France SAS: French subsidiary. Searched for Israeli software, cloud and military technology relationships; searched, none found.⁷
• ulrich medical España S.L.: Spanish subsidiary. Searched for Israeli software procurement and defence technology relationships; searched, none found.⁸
• Christophe Martinez: Spanish General Manager. Searched for Israeli technology and defence relationships; searched, none found.⁸
• ULRICH Swiss: Independent distributor. Searched for Ulrich Medical digital technology sales and Israeli military or settlement relationships; searched, none found.⁹
• Synapse Medical: European distributor. Searched for Ulrich Medical software deployment and Israeli security-sector relationships; searched, none found.¹³
• GE Healthcare: Commercial partner. Searched for Ulrich Medical technology distribution involving Israeli defence and government infrastructure; searched, none found.¹²
• Bracco Imaging: Commercial partner. Searched for Ulrich Medical technology relationships involving Israeli defence and government institutions; searched, none found.¹¹

No complete shareholder register identifying every natural or legal person holding at least 10% of the German parent was obtained. Consequently, the named-entity record does not establish an exhaustive list of beneficial owners.^{1, 2}

Surveillance, Biometrics & Retail Technology

Facial recognition and biometric identification

No public evidence identified of Ulrich Medical deploying facial-recognition, gait-recognition or identity-matching systems supplied by Trigo, BriefCam, AnyVision/Oosto, Trax or comparable Israeli-origin technology vendors.

Predictive monitoring

No public evidence identified of Israeli-origin predictive policing, social-media monitoring, sentiment analysis or workforce-surveillance technology procurement by Ulrich Medical.

Medical technology and patient information

Ulrich Medical publishes a RIS/PACS Interface software option for CT motion injectors. Its technical description identifies automated transfer of imaging and injection information into hospital picture-archiving systems using the DICOM standard. The product page was publicly available in October 2026; its original commercial launch date is not established there.¹⁴

Ulrich Medical also states that its RIS/PACS integration can transfer injection parameters to hospital PACS or dose-management systems for documentation and statistical evaluation. The company’s published material does not identify Israeli hospitals as customers of this specific software option.¹⁵

Third-party deployment

No public evidence identified of Israeli-origin biometric or surveillance products being deployed indirectly within Ulrich Medical through managed service providers or bundled enterprise software.

Israeli distribution relationship

Gil Medical Group publicly lists ulrich medical among its commercial partners. Gil Medical describes itself as operating in Israel since 1972 and providing nationwide medical-device distribution and customer support. The website establishes a publicly represented commercial channel involving an Israeli distributor, but does not identify specific Ulrich Medical software features supplied through it. The date on which the Ulrich Medical relationship commenced is unknown; the partner listing was visible in October 2026.¹⁶

Act record - Israeli distributor

• Acting entity: Gil Medical Group.
• Commercial counterparty: ulrich medical / ulrich GmbH & Co. KG.
• Beneficiaries: Medical-sector customers served by the distributor; individual institutions are not identified.
• Channel: gilmedical.co.il, the distributor’s own website.
• Earliest verified observation: Public partner listing examined in October 2026.
• Latest verified observation: 28 October 2026.
• Status: Publicly represented as current; original start date, individual transactions and contractual termination provisions unknown.
• Communication audience: Public visitors to the distributor’s website.
• Persistence: Duration before the October 2026 observation is unverified.
• Digital-product scope: No specifically documented RIS/PACS, SYNCopen, cloud or surveillance implementation in Israel.¹⁶

Cloud Infrastructure, Data Residency & Sovereign Cloud Participation

Cloud infrastructure

No public evidence identified of Ulrich Medical owning, leasing or operating a data centre in Israel.

No public evidence identified of Ulrich Medical participating in Project Nimbus, Israeli government sovereign-cloud programmes or equivalent Israeli state infrastructure contracts.

Customer and employee data

Ulrich Medical’s privacy statement identifies customer-contact processing, website analytics, newsletters, Microsoft Teams and an online customer portal. It describes categories of processed personal data, service-provider involvement and applicable data-transfer arrangements. The statement does not establish that Ulrich Medical operates an Israeli-hosted database.¹⁰

The privacy statement identifies uPortal as a customer-facing service requiring account registration and processing of names, customer numbers, email addresses and login credentials. It also describes user-management, communication and account-security functions. The published policy states that data is not transferred to third countries for the specified portal processing. The exact server location and detailed infrastructure architecture are not identified.¹⁰

For Microsoft Teams, the privacy statement acknowledges potential processing outside the European GDPR area, including the United States. It does not specify an Israeli processing region.¹⁰

For Google Analytics 4, the privacy statement describes website-interaction collection and processing of analytics information. It does not identify Israel as a storage or processing jurisdiction.¹⁰

Medical-device data flow

Ulrich Medical’s RIS/PACS Interface transfers injection and examination information through DICOM into hospital information systems. Its published product description identifies PACS as a destination for the resulting documentation, but does not identify a manufacturer-operated central cloud as the destination.¹⁴

SYNCopen provides an interface between compatible Ulrich Medical injectors and CT scanners. Its stated functions include integration of injection protocols and reduction of duplicate data entry. No Israeli cloud-processing destination is identified in the product disclosure.¹⁷

Data sovereignty

No public evidence identified of Ulrich Medical marketing data-residency, sovereign-cloud or infrastructure-resilience services to Israeli state institutions.

Data-exposure investigation

No public evidence identified that Ulrich Medical’s customer-account records, website analytics, injector-generated medical information or hospital integration services are stored, processed or routed through Israeli jurisdiction.

The locations of every third-party processor, subprocessor and hospital-installed system cannot be established from the examined disclosures.^{10, 14}

Defence, Intelligence & Security Sector Technology Relationships

Israeli military and intelligence contracts

No public evidence identified of a digital technology contract between ulrich GmbH & Co. KG, its identified subsidiaries or their controlling principals and the Israeli Ministry of Defence, Israel Defense Forces or Israeli intelligence agencies.

Medical-device distributor

Gil Medical’s public website lists ulrich medical as a partner and describes nationwide Israeli medical-device distribution. The page does not identify the IDF, Israeli Ministry of Defence or an intelligence organisation as an Ulrich Medical customer.¹⁶

Dual-use technology

The CT motion injector includes software functions for injection preparation and delivery, including configurable timing, pauses and injection management. These are described as clinical imaging functions; the product disclosure does not establish any Israeli military application.¹⁸

The CT motion SPICY product likewise includes standard and licensed software functions for contrast-media administration. The examined product description provides no evidence of military intelligence, surveillance or weapons-related deployment.¹⁹

Offensive cyber capabilities

No public evidence identified of Ulrich Medical developing, licensing, selling or maintaining exploit frameworks, intrusion software, offensive cyber platforms or digital weapons.

Purpose-built weapons and targeting software

No public evidence identified of Ulrich Medical producing software primarily designed for autonomous target generation, fire control or kinetic weapons effects.

Settlement deployment

No public evidence identified of Ulrich Medical software or digital services being installed in an Israeli settlement, military installation within occupied territory, or settlement-related government information system.

Constructive-notice chronology

Ulrich Medical publicly announced the appointment of Friedrich von Rechteren on 22 July 2024 and described international commercial partnerships at that date. The announcement postdates 19 July 2024, but does not document an Israeli military, surveillance or government-cloud technology relationship.¹¹

Gil Medical’s publicly available partner listing was observed in October 2026, after both 19 July 2024 and November 2024. The record does not establish the start date or continuation dates of particular Ulrich Medical software deliveries, contracts or maintenance activities.¹⁶

No public evidence identified permitting an independently dated finding that Ulrich Medical continued a specific military, settlement or surveillance-related digital service after either reference date.

AI, Algorithmic & Autonomous Systems

Artificial intelligence products

No public evidence identified of Ulrich Medical providing a proprietary general-purpose AI platform to Israeli state, military or intelligence institutions.

Clinical software

Ulrich Medical markets software-assisted contrast-media injection functions and integration with hospital information systems. The published CT motion and CT motion SPICY feature lists concern clinical injection management; they do not identify autonomous military decision-support functions.^{18, 19}

AI training data

No public evidence identified of Ulrich Medical AI models being trained on Israeli civilian surveillance records, intercepted communications or data collected in occupied territories.

Military AI provision

No public evidence identified of Ulrich Medical supplying computer-vision, intelligence analysis, autonomous tracking or target-generation systems to Israeli military or security organisations.

Predictive analytics

Ulrich Medical describes statistical evaluation of injection parameters through RIS/PACS integration for radiology process improvement. The disclosed clinical functionality does not establish provision of predictive policing, population surveillance or military AI systems.¹⁵

Autonomous systems

No public evidence identified of Ulrich Medical providing autonomous lethal systems or automated threat-detection platforms to Israeli authorities.

Technology Ecosystem & R&D Footprint

Research and development

Ulrich Medical’s corporate history describes an engineering and manufacturing base in Germany, including the Blaustein-Herrlingen manufacturing facility established in 1975. It also documents decades of development in medical imaging and spinal systems. Historical events before 2020 are [pre-2020]; the company’s current public profile continues to identify Germany as its main development and manufacturing base.^{2, 20}

Ulrich Medical’s current US subsidiary description identifies development of products tailored to North American market needs at its Dallas-area operation. The page describes these activities as current in October 2026.⁶

No public evidence identified of Ulrich Medical operating an Israeli research laboratory, technology accelerator, software engineering office or AI research centre.

Product development

Ulrich Medical publicly describes the RIS/PACS Interface as a software option using DICOM-based hospital systems integration. It identifies functions including automated transfer of patient examination and injection information into PACS.¹⁴

The company also publishes a CT-scanner interface under the SYNCopen name. The product description identifies CT-scanner synchronisation and clinical workflow integration, including compatibility with CT motion and CT motion SPICY.¹⁷

Digital customer interfaces

On 8 August 2024, Ulrich Medical announced a redesigned corporate website featuring an interactive spinal-system selector and a virtual demonstration of the RIS/PACS Interface. The communication was published to the general public through ulrichmedical.com. Its continued availability was verified in October 2026; the announcement does not identify Israeli development or hosting contractors.²¹

RAD Magazine separately described the interactive spine and RIS/PACS website demonstration in its reporting on the company’s 2024 redesign. That account identifies the same digital presentation features but does not disclose their underlying technology contractors.²²

On 27 June 2025, Ulrich Medical reported receiving awards for its brand strategy and website, referring again to its interactive spine and RIS/PACS demonstration. The public communication remained available in October 2026.²³

Technology communication act record

• Acting entity: ulrich GmbH & Co. KG.
• Recipient: Public website visitors, including medical professionals.
• Channel: ulrichmedical.com, the company’s own website.
• Earliest dated observation: 8 August 2024.
• Latest observation: October 2026.
• Status: Public announcement and associated product demonstrations remained accessible.
• Persistence: Approximately 26 months between the dated announcement and research date.
• Audience: General public and medical professionals.
• Israel nexus: No Israeli developer, hosting provider or technology partner identified.^{21, 23}

Acquisitions and investments

No public evidence identified of Ulrich Medical acquiring an Israeli technology company or investing in an Israeli cyber, AI, surveillance or military-technology startup.

No public evidence identified of a named controlling principal holding a verified investment in an Israeli surveillance, intelligence or military-technology business.

Patents and intellectual property

No public evidence identified of a patent co-assignment, technology-licensing agreement or co-development contract between Ulrich Medical and an Israeli-domiciled university, research institution or technology company.

Historical corporate development

The company’s corporate history identifies establishment of its US subsidiary in 2006 and its French subsidiary in 2017. Both events are [pre-2020]; the corresponding entities remain included in Ulrich Medical’s current corporate locations disclosure.^{2, 5}

Civil Society Scrutiny & Regulatory History

NGO and UN investigations

No public evidence identified in the searches performed of an NGO investigation specifically documenting an Ulrich Medical digital technology contract with an Israeli state, intelligence or military institution.

No public evidence identified in the searches performed linking Ulrich Medical’s RIS/PACS Interface, SYNCopen or uPortal to surveillance or settlement-related technology programmes.

The research did not establish a verified named entry for Ulrich Medical or its identified controlling principals in the searched UN settlement-related materials.

Civil-society campaigns

No public evidence identified of an organised boycott or divestment campaign specifically targeting Ulrich Medical for Israeli surveillance, cloud computing, biometric technology or military software provision.

No public evidence identified of a company response to such a technology-specific campaign.

Regulatory investigations

No public evidence identified of sanctions enforcement, export-control proceedings or regulatory inquiries involving Ulrich Medical’s provision of digital services to Israeli military or intelligence bodies.

Commercial and technology disclosures

Ulrich Medical’s official news archive records continuing commercial development, management changes and medical-device product announcements during 2024–2026. The examined announcements do not identify an Israeli military or government-cloud software contract.²⁴

The company’s 22 January 2025 financial announcement reported 2024 group revenue of €163 million and described medical-device product growth. The statement did not allocate revenue to Israeli digital technology customers.²⁵

Group-attribution investigation

The examined subsidiary profiles identify Ulrich Medical operations in the United States, France and Spain. No specific Israeli defence, intelligence, government-cloud or settlement technology contract was identified for any of those named subsidiaries.^{6, 7, 8}

The independent Swiss distributor publicly describes a medical-device distribution relationship with Ulrich Medical. No Israeli digital technology contract involving that distributor was verified.⁹

Gil Medical publicly identifies Ulrich Medical as a commercial partner in Israel. The disclosed relationship establishes an Israeli market connection but contains no verified recipient-level evidence of military, surveillance or settlement-related digital technology provision.¹⁶